Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech, Trend reports with reference to Reuters.
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.